Geode Capital Management’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q4
Sell
-793,321
Closed -$14.7M 4768
2023
Q3
$14.7M Buy
793,321
+180,354
+29% +$3.34M ﹤0.01% 2021
2023
Q2
$6.78M Buy
612,967
+13,629
+2% +$151K ﹤0.01% 2531
2023
Q1
$8.05M Buy
599,338
+14,344
+2% +$193K ﹤0.01% 2392
2022
Q4
$7.24M Buy
584,994
+137,216
+31% +$1.7M ﹤0.01% 2458
2022
Q3
$6.25M Buy
447,778
+10,571
+2% +$147K ﹤0.01% 2549
2022
Q2
$6.04M Buy
437,207
+44,144
+11% +$610K ﹤0.01% 2596
2022
Q1
$6.4M Sell
393,063
-89,677
-19% -$1.46M ﹤0.01% 2644
2021
Q4
$7.86M Sell
482,740
-14,896
-3% -$243K ﹤0.01% 2612
2021
Q3
$7.39M Buy
497,636
+8,971
+2% +$133K ﹤0.01% 2685
2021
Q2
$9.76M Buy
488,665
+26,125
+6% +$522K ﹤0.01% 2473
2021
Q1
$10.7M Buy
462,540
+57,413
+14% +$1.33M ﹤0.01% 2320
2020
Q4
$10M Buy
405,127
+3,112
+0.8% +$76.9K ﹤0.01% 2182
2020
Q3
$16.7M Buy
402,015
+5,553
+1% +$230K ﹤0.01% 1647
2020
Q2
$19M Buy
396,462
+13,993
+4% +$670K ﹤0.01% 1546
2020
Q1
$24.1M Buy
382,469
+23,187
+6% +$1.46M 0.01% 1174
2019
Q4
$44.5M Buy
359,282
+26,868
+8% +$3.33M 0.01% 1026
2019
Q3
$22.1M Buy
332,414
+3,744
+1% +$248K 0.01% 1416
2019
Q2
$26.2M Buy
328,670
+51,012
+18% +$4.06M 0.01% 1304
2019
Q1
$31.1M Buy
277,658
+17,772
+7% +$1.99M 0.01% 1116
2018
Q4
$26.2M Buy
259,886
+22,059
+9% +$2.22M 0.01% 1091
2018
Q3
$30.1M Buy
237,827
+18,467
+8% +$2.33M 0.01% 1127
2018
Q2
$18.4M Buy
219,360
+54,044
+33% +$4.53M 0.01% 1419
2018
Q1
$10.2M Buy
165,316
+5,650
+4% +$348K ﹤0.01% 1752
2017
Q4
$9.33M Sell
159,666
-1,939
-1% -$113K ﹤0.01% 1788
2017
Q3
$9.38M Buy
161,605
+9,664
+6% +$561K ﹤0.01% 1778
2017
Q2
$18.4M Buy
151,941
+7,811
+5% +$946K 0.01% 1249
2017
Q1
$16.3M Buy
144,130
+16,392
+13% +$1.85M 0.01% 1306
2016
Q4
$13.9M Buy
127,738
+7,248
+6% +$787K 0.01% 1367
2016
Q3
$19.8M Buy
120,490
+2,613
+2% +$430K 0.01% 1004
2016
Q2
$16.8M Buy
117,877
+5,104
+5% +$728K 0.01% 1056
2016
Q1
$14.5K Buy
112,773
+3,654
+3% +$469 0.01% 1124
2015
Q4
$16.3M Buy
109,119
+6,245
+6% +$933K 0.01% 1030
2015
Q3
$17.1M Buy
102,874
+19,375
+23% +$3.21M 0.01% 970
2015
Q2
$20.2M Buy
83,499
+8,666
+12% +$2.09M 0.01% 930
2015
Q1
$21.1M Buy
74,833
+10,406
+16% +$2.93M 0.01% 890
2014
Q4
$10.1M Buy
64,427
+2,077
+3% +$324K 0.01% 1337
2014
Q3
$14.8M Buy
62,350
+832
+1% +$197K 0.01% 1009
2014
Q2
$14.6M Buy
61,518
+2,545
+4% +$602K 0.01% 1028
2014
Q1
$19.4M Buy
58,973
+112
+0.2% +$36.9K 0.01% 836
2013
Q4
$4.02M Buy
58,861
+19,472
+49% +$1.33M ﹤0.01% 1860
2013
Q3
$2.72M Buy
39,389
+15,259
+63% +$1.05M ﹤0.01% 1989
2013
Q2
$1.08M Buy
+24,130
New +$1.08M ﹤0.01% 2415